Home » Current Affairs In-depths & Editorials » Compilations » Schemes/Welfare Initiatives » National Sickle Cell Anaemia Elimination Mission

National Sickle Cell Anaemia Elimination Mission

Swetha 05/07/2023

National Sickle Cell Anaemia Elimination Mission
News
Launch location: Shahdol, Madhya Pradesh
Release of guidelines and training modules
Cover primary, secondary and tertiary care
Awareness module
Counselling module
Sickle Cell Genetic Status Cards
PM handed over to beneficiaries
What
Aim: Eliminate sickle cell anaemia by 2047
Under National Health Mission
Sickle Cell Anaemia
Chronic single gene disorder
Causes RBCs to acquire distorted shape
Inherit defective gene from both parents to get disease
Causes
Impediment to smooth blood flow in capillaries
Anaemia
Persistent pain
Organ damage
Stroke
Other complications
How
Comprehensive approach
Combines screening and awareness
Ensures early detection and treatment
Screening across 278 districts
Age group: 0-40 years
Sickle Cell Genetic Status Cards
Beneficiaries can determine risk for future children
2023-24 to 2025-26 period
7 crore people to be screened
Where
17 high priority states
Gujarat
Maharashtra
Rajasthan
Madhya Pradesh
Jharkhand
Chhattisgarh
West Bengal
Odisha
Tamil Nadu
Telangana
Andhra Pradesh
Karnataka
Assam
Uttar Pradesh
Kerala
Bihar
Uttarakhand

If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.

Related Posts

Anti-cancer Drug Camptothecin mind map Recent News Indian Institute of Technology Research IIT Madras IIT Mandi Nothapodytes nimmoniana Increased Camptothecin production Sustainable source identification Microbial fermentation process What Alkaloid From Camptotheca acuminata Topoisomerase I inhibitor Treats various cancers Ovarian, Cervical, Colon Pancreatic, Lung, Breast Prostate, Brain Limitations Poor solubility Inactivity under physiological conditions How Blocks DNA topoisomerase 1 Attenuates cancer cell replication Active lactone form Binds DNA topoisomerase I cleavage complex Significance Wide-spectrum anti-tumor activity Development of soluble analogues Irinotecan, Topotecan 9-Aminocamptothecin, GI 147211C Novel mechanism of action Challenges Instability Low solubility Significant toxicity Tumor cell resistance Development of nanomedicines Improved pharmacokinetic profiles Pharmacodynamic profiles Way Forward Development of combination regimens Pursuit of randomized trials Focus on specific cancers Colorectal cancer Non-small-cell lung cancer Small-cell lung cancer Ovarian carcinoma Preclinical insights Efficacy, Schedule dependency Combination strategies Resistance mechanisms

Anti-cancer Drug Camptothecin

08/01/2024 / Diseases

Covid Lessons for TB

Covid Lessons for TB

26/03/2022 / Diseases, Health

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

18/08/2023 / Diseases

H5N1 Outbreak Devastates Elephant Seal Population

H5N1 Outbreak Devastates Elephant Seal Population

23/11/2024 / Diseases

Categories: Diseases, Schemes/Welfare Initiatives

Tags: 05.07.2023, Newsbits

Subscribe

0 Comments

Inline Feedbacks

View all comments

X